Other investors include the Partners Innovation Fund, affiliated with hospital system Partners HealthCare, and N.J.-based drug maker The Medicines Company. The funding may be expanded to $11 million and is expected to carry the startup through pre-clinical development to clinical proof of concept of Annovation’s lead product.
The product is based on technology from Douglas Raine, MD, and his laboratory in the department of anesthesia, critical care, and pain medicine at Massachusetts General Hospital in Boston.
Related Articles on Anesthesia:
Clinical Trial Shows Drug Exparel Reduces Pain, Adverse Opioid Side Effects
Donald Bell Named First CRNA to Chair Tennessee Board of Nursing
Sheridan Healthcare Names Dr. Andrew Greenfield Senior VP of Anesthesiology
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
